Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial. - Wikidata - awgldk - TriplyDB

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.

http://www.wikidata.org/entity/Q30409095

about

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy Vilanterol and fluticasone furoate for asthma.Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.Assessing the viability of long-acting β2-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective.

P2860

Q28074802-4F158E4F-E828-4829-AF32-5F4E9157B076 Q34539126-D0943450-AE15-4ADD-AE75-FE8C79A601DE Q36765438-507B18F4-D2E0-4C02-BEB8-816E89931CF4 Q38669520-651E6467-5C36-4DAF-9D05-504F709A8DE6 Q38733745-94AC60A8-0194-4CCA-83E4-9DBF833C6708 Q38851423-72948CEB-D6B9-42A2-A7A2-E06280B5359C Q38951196-FEE3B0A5-7FF1-4584-9933-ED33469F9D94

P2860

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.

http://www.wikidata.org/entity/Q30409095

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@ast

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@en

type

label

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@ast

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@en

prefLabel

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@ast

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@en

P1433

Q30409095-509C4B24-5AC3-4C2E-9AB6-76FCE0E8EC3D

P1476

Q30409095-7D6B28E4-1F84-477D-9F2F-85EBF11AB185

P2093

Q30409095-05C33C89-EDF2-4B35-9B4A-25EEB3277A0D

Q30409095-743C913C-3D41-446A-BB87-5C6FE2D2430A

Q30409095-8CBB232F-9C5D-46AD-B944-BBC93C1D3709

Q30409095-944E561D-A234-4B2E-8D7F-64E4C4F83667

Q30409095-A1933D25-1259-4223-AF8E-68E6814864A1

Q30409095-D6471813-51A0-45A9-B7AA-DF1ABD11310E

Q30409095-DC90A9F1-623D-4EEA-B3E1-930067DB96E1

P2860

Q30409095-1E848962-04B4-4902-A54A-6C978DDAAFFC

Q30409095-356F708F-9CAD-4485-B969-61432B5E11A0

Q30409095-35C8904E-51EF-4D6B-AA94-960CBDCCB4C5

Q30409095-463D752D-16D2-4EA5-8A13-2D4DDD9F942E

Q30409095-6EFDA49F-9ECE-4F7E-AAC8-61491C290FFB

Q30409095-84536DA5-64DF-47AC-8EBE-C08485BB12F2

Q30409095-9779579E-C604-463C-A6F0-F5ECD265A8B3

Q30409095-B454C135-D1DE-4362-8FCC-C3EF9CFD7807

Q30409095-E1D5E5EC-4720-4AF2-B19F-C41F1A19F7EF

Q30409095-E3DC084C-65A0-4925-BDBC-079EDC4B1E46

P304

Q30409095-AB8C4E11-F2ED-4C77-B246-3824966B83A0

P31

Q30409095-9A44D6F1-8F31-4FE7-98C5-F2AAB306533F

P356

Q30409095-1DF71AB4-50DF-43F6-A0C8-9C317FCEA81F

P433

Q30409095-61465985-EC7F-40B7-87B7-4668BE1F4473

P478

Q30409095-353CEF1B-EE55-484B-B64D-C023C2926091

P577

Q30409095-BA7411EF-240A-494E-B5D2-2BFBBED57706

P5875

Q30409095-65235409-558F-4F88-96E6-7352BE0AF970

P698

Q30409095-599F051B-2B2D-4A2D-82F5-EF50B10FCD3C

P921

Q30409095-5769EE8F-C311-4638-8BCC-BBB7AEA943C8

Q30409095-5F011F99-3379-4BF3-AF28-9848AE44133D

Q30409095-D729AB5F-6D77-459F-9FB3-BFE5BB08FC37

P932

Q30409095-76F1837E-5EE5-4291-B379-BAF248E1ECAA

P356

P1433

Clinical pharmacology in drug development

P1476

Safety, Tolerability, Pharmaco ...... nt Asthma: A Randomized Trial.

@en

P2093

Amanda Oliver

http://www.w3.org/2001/XMLSchema#string

Ann Allen

http://www.w3.org/2001/XMLSchema#string

Lee Tombs

http://www.w3.org/2001/XMLSchema#string

Melanie Hamilton

http://www.w3.org/2001/XMLSchema#string

Paul Qaqundah

http://www.w3.org/2001/XMLSchema#string

Rodger Kempsford

http://www.w3.org/2001/XMLSchema#string

Sandi VanBuren

http://www.w3.org/2001/XMLSchema#string

P2860

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.

Advances in pediatric asthma in 2010: addressing the major issues

Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial.

Pediatric asthma: a different disease

Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.

Asthma Control Questionnaire in children: validation, measurement properties, interpretation.

24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids.

Status of asthma control in pediatric primary care: results from the pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS).

P304

215-221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.92

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259536882

http://www.w3.org/2001/XMLSchema#string

P698

26097789

http://www.w3.org/2001/XMLSchema#string

P921

pharmacokinetics

pharmacodynamics

P932

4467260

http://www.w3.org/2001/XMLSchema#string